September 2026 results: H1 revenue up 52%, profit up 57%
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals published board-approved unaudited results for September 2026. Standalone half-year revenue rose 51.8% to Rs 6,930.82 million and profit after tax rose 57.3% to Rs 886.43 million; EPS was Rs 2.70. Q2 revenue rose 15.4% to Rs 3,645.97 million, but profit after tax fell 5.8% to Rs 514.54 million. Consolidated half-year revenue was Rs 8,674.79 million and profit Rs 938.71 million.
Strong half-year growth may support sentiment, but the Q2 profit fall signals near-term margin pressure and could weigh on the stock.